Skip directly to Accessibility Notice
  • VanEck Blog - Emerging Markets Equity

     Emerging Markets Equity
    Emerging Markets Equity

    David Semple, Portfolio Manager, Emerging Markets Equity Strategy

    Oksana Miller , Product Manager

    If you look past short-term headlines and focus on long-term, structural growth opportunities, healthcare in China is poised for innovation and disruption as evidenced by Ping An Good Doctor and BeiGene.

    Emerging Markets Equity

    March 24, 2020

    Harnessing Growth: WuXi Biologics and the Race for a COVID-19 Vaccine

    by Dominic Jacobson, Analyst,

    David Semple, Portfolio Manager, Emerging Markets Equity Strategy

    WuXi Biologics, a leading Chinese healthcare name, is an example of how pockets of alpha can be found where companies are providing solutions to problems caused by the novel coronavirus outbreak.

     Read more
    Emerging Markets Equity

    March 09, 2020

    FA Magazine: Will Your International Portfolio Withstand the Changing Times?

    by David Semple, Portfolio Manager, Emerging Markets Equity Strategy

    In the FA Magazine, Portfolio Manager David Semple discusses the market outlook for global growth and shares his insights on global trade, China and the impact of coronavirus.

     Read more
    Emerging Markets Equity

    January 15, 2020

    Emerging Markets Equity: Structural Growth at the Front and Center in 2020

    by David Semple, Portfolio Manager, Emerging Markets Equity Strategy

    We believe the outlook for emerging markets equities is bright and expect growth to be the main driver of returns in 2020.

     Read more
    Emerging Markets Equity

    December 16, 2019

    Our Active Emerging Markets Solution vs. Passive Investing

    by David Semple, Portfolio Manager, Emerging Markets Equity Strategy,

    Oksana Miller , Product Manager

    In this white paper, we reflect on the relative role, advantages and disadvantages of active vs. passive investing in emerging markets.

     Read more